These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 30383836)

  • 1. Ten years of antiretroviral therapy: Incidences, patterns and risk factors of opportunistic infections in an urban Ugandan cohort.
    Weissberg D; Mubiru F; Kambugu A; Fehr J; Kiragga A; von Braun A; Baumann A; Kaelin M; Sekaggya-Wiltshire C; Kamya M; Castelnuovo B
    PLoS One; 2018; 13(11):e0206796. PubMed ID: 30383836
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Earlier initiation of antiretroviral therapy, increased tuberculosis case finding and reduced mortality in a setting of improved HIV care: a retrospective cohort study.
    Hermans SM; van Leth F; Manabe YC; Hoepelman AI; Lange JM; Kambugu A
    HIV Med; 2012 Jul; 13(6):337-44. PubMed ID: 22296211
    [TBL] [Abstract][Full Text] [Related]  

  • 3. AIDS-related opportunistic illnesses occurring after initiation of potent antiretroviral therapy: the Swiss HIV Cohort Study.
    Ledergerber B; Egger M; Erard V; Weber R; Hirschel B; Furrer H; Battegay M; Vernazza P; Bernasconi E; Opravil M; Kaufmann D; Sudre P; Francioli P; Telenti A
    JAMA; 1999 Dec; 282(23):2220-6. PubMed ID: 10605973
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Opportunistic infections among people living with HIV/AIDS attending antiretroviral therapy clinics in Gedeo Zone, Southern Ethiopia.
    Gebremichael G; Tadele N; Gebremedhin KB; Mengistu D
    BMC Res Notes; 2024 Aug; 17(1):225. PubMed ID: 39148100
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factors associated with the development of opportunistic infections in HIV-1-infected adults with high CD4+ cell counts: a EuroSIDA study.
    Podlekareva D; Mocroft A; Dragsted UB; Ledergerber B; Beniowski M; Lazzarin A; Weber J; Clumeck N; Vetter N; Phillips A; Lundgren JD;
    J Infect Dis; 2006 Sep; 194(5):633-41. PubMed ID: 16897662
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence and determinants of mortality and morbidity following early antiretroviral therapy initiation in HIV-infected adults in West Africa.
    Moh R; Danel C; Messou E; Ouassa T; Gabillard D; Anzian A; Abo Y; Salamon R; Bissagnene E; Seyler C; Eholié S; Anglaret X
    AIDS; 2007 Nov; 21(18):2483-91. PubMed ID: 18025885
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of immediate initiation of antiretroviral therapy on risk of severe bacterial infections in HIV-positive people with CD4 cell counts of more than 500 cells per μL: secondary outcome results from a randomised controlled trial.
    O'Connor J; Vjecha MJ; Phillips AN; Angus B; Cooper D; Grinsztejn B; Lopardo G; Das S; Wood R; Wilkin A; Klinker H; Kantipong P; Klingman KL; Jilich D; Herieka E; Denning E; Abubakar I; Gordin F; Lundgren JD;
    Lancet HIV; 2017 Mar; 4(3):e105-e112. PubMed ID: 28063815
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of opportunistic illness on HIV RNA viral load and CD4+ T cell count among HIV-positive adults taking antiretroviral therapy.
    Ekwaru JP; Campbell J; Malamba S; Moore DM; Were W; Mermin J
    J Int AIDS Soc; 2013 Apr; 16(1):17355. PubMed ID: 23547778
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A decade of antiretroviral therapy in Uganda: what are the emerging causes of death?
    Kiragga AN; Mubiru F; Kambugu AD; Kamya MR; Castelnuovo B
    BMC Infect Dis; 2019 Jan; 19(1):77. PubMed ID: 30665434
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence of common opportunistic infections among HIV-infected children on ART at Debre Markos referral hospital, Northwest Ethiopia: a retrospective cohort study.
    Melkamu MW; Gebeyehu MT; Afenigus AD; Hibstie YT; Temesgen B; Petrucka P; Alebel A
    BMC Infect Dis; 2020 Jan; 20(1):50. PubMed ID: 31948393
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Trial of Early Antiretrovirals and Isoniazid Preventive Therapy in Africa.
    ; Danel C; Moh R; Gabillard D; Badje A; Le Carrou J; Ouassa T; Ouattara E; Anzian A; Ntakpé JB; Minga A; Kouame GM; Bouhoussou F; Emieme A; Kouamé A; Inwoley A; Toni TD; Ahiboh H; Kabran M; Rabe C; Sidibé B; Nzunetu G; Konan R; Gnokoro J; Gouesse P; Messou E; Dohoun L; Kamagate S; Yao A; Amon S; Kouame AB; Koua A; Kouamé E; Ndri Y; Ba-Gomis O; Daligou M; Ackoundzé S; Hawerlander D; Ani A; Dembélé F; Koné F; Guéhi C; Kanga C; Koule S; Séri J; Oyebi M; Mbakop N; Makaila O; Babatunde C; Babatounde N; Bleoué G; Tchoutedjem M; Kouadio AC; Sena G; Yededji SY; Assi R; Bakayoko A; Mahassadi A; Attia A; Oussou A; Mobio M; Bamba D; Koman M; Horo A; Deschamps N; Chenal H; Sassan-Morokro M; Konate S; Aka K; Aoussi E; Journot V; Nchot C; Karcher S; Chaix ML; Rouzioux C; Sow PS; Perronne C; Girard PM; Menan H; Bissagnene E; Kadio A; Ettiegne-Traore V; Moh-Semdé C; Kouame A; Massumbuko JM; Chêne G; Dosso M; Domoua SK; N'Dri-Yoman T; Salamon R; Eholié SP; Anglaret X
    N Engl J Med; 2015 Aug; 373(9):808-22. PubMed ID: 26193126
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk factors for opportunistic illnesses in children with human immunodeficiency virus in the era of highly active antiretroviral therapy.
    Ylitalo N; Brogly S; Hughes MD; Nachman S; Dankner W; Van Dyke R; Seage GR;
    Arch Pediatr Adolesc Med; 2006 Aug; 160(8):778-87. PubMed ID: 16894075
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Frequency and impact of suboptimal immune recovery on first-line antiretroviral therapy within the International Epidemiologic Databases to Evaluate AIDS in East Africa.
    Nakanjako D; Kiragga AN; Musick BS; Yiannoutsos CT; Wools-Kaloustian K; Diero L; Oyaro P; Lugina E; Ssali JC; Kambugu A; Easterbrook P
    AIDS; 2016 Jul; 30(12):1913-22. PubMed ID: 26959510
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidence of AIDS-Defining Opportunistic Infections and Mortality during Antiretroviral Therapy in a Cohort of Adult HIV-Infected Individuals in Hanoi, 2007-2014.
    Tanuma J; Lee KH; Haneuse S; Matsumoto S; Nguyen DT; Nguyen DT; Do CD; Pham TT; Nguyen KV; Oka S
    PLoS One; 2016; 11(3):e0150781. PubMed ID: 26939050
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Natural history of opportunistic disease in an HIV-infected urban clinical cohort.
    Moore RD; Chaisson RE
    Ann Intern Med; 1996 Apr; 124(7):633-42. PubMed ID: 8607591
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low uptake of antiretroviral therapy after admission with human immunodeficiency virus and tuberculosis in KwaZulu-Natal, South Africa.
    Murphy RA; Sunpath H; Taha B; Kappagoda S; Maphasa KT; Kuritzkes DR; Smeaton L
    Int J Tuberc Lung Dis; 2010 Jul; 14(7):903-8. PubMed ID: 20550776
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence and risk factors of major opportunistic infections after initiation of antiretroviral therapy among advanced HIV-infected patients in a resource-limited setting.
    Manosuthi W; Chaovavanich A; Tansuphaswadikul S; Prasithsirikul W; Inthong Y; Chottanapund S; Sittibusaya C; Moolasart V; Termvises P; Sungkanuparph S
    J Infect; 2007 Nov; 55(5):464-9. PubMed ID: 17714788
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence and predictors of common opportunistic infections among children living with HIV at Bahir Dar City, Ethiopia.
    Kerebeh G; Kefale D; Chanie ES; Moges N; Feleke DG; Kassaw A; Tigabu A; Bantie B; Amare AT; Yirga GK; Mengesha T; Embiale T; Azmeraw M; Fetene S; Bayih WA; Shiferaw K; Alene T; Endalamaw A
    Sci Rep; 2024 Oct; 14(1):23403. PubMed ID: 39379418
    [TBL] [Abstract][Full Text] [Related]  

  • 19. No differences in clinical outcomes with the addition of viral load testing to CD4 cell count monitoring among HIV infected participants receiving ART in rural Uganda: Long-term results from the Home Based AIDS Care Project.
    Okoboi S; Ekwaru PJ; Campbell JD; Egessa A; King R; Bakanda C; Muramuzi E; Kaharuza F; Malamba S; Moore DM
    BMC Public Health; 2016 Feb; 16():101. PubMed ID: 26830678
    [TBL] [Abstract][Full Text] [Related]  

  • 20. AIDS and non-AIDS morbidity and mortality across the spectrum of CD4 cell counts in HIV-infected adults before starting antiretroviral therapy in Cote d'Ivoire.
    Anglaret X; Minga A; Gabillard D; Ouassa T; Messou E; Morris B; Traore M; Coulibaly A; Freedberg KA; Lewden C; Ménan H; Abo Y; Dakoury-Dogbo N; Toure S; Seyler C;
    Clin Infect Dis; 2012 Mar; 54(5):714-23. PubMed ID: 22173233
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.